Stents

• 

  Subject Areas on Research

  • 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Developed in collaboration with the American Academy of Neurology and Society of Cardiovascular Computed Tomography. 
  • 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. 
  • 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. 
  • 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial. 
  • A Hybrid Approach to Radiation-Induced Axillary Artery Hemorrhage. 
  • A New Protocol for Anticoagulation With Tirofiban During Flow Diversion. 
  • A comparison of clinical outcomes between Canadian and American patients after nonurgent coronary stenting. 
  • A comparison of operation, endoscopic retrograde cholangiopancreatography, and percutaneous transhepatic cholangiography in biliary complications after hepatic transplantation. 
  • A comparison of the bioeffects of four different modes of stone therapy on renal function and morphology. 
  • A matched case-control study of preoperative biliary drainage in patients with pancreatic adenocarcinoma: routine drainage is not justified. 
  • A new wave in treatment of vascular occlusive disease: biodegradable stents--clinical experience and scientific principles. 
  • A novel Schlemm's Canal scaffold increases outflow facility in a human anterior segment perfusion model. 
  • A polymer-metal composite stent. 
  • A prospective evaluation of surgically treated groin complications following percutaneous cardiac procedures. 
  • A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial infarction: Rationale and design of the PRESERVATION I trial. 
  • A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial. 
  • A systematic review of venous stents for iliac and venacaval occlusive disease. 
  • ACP Journal Club. Review: CABG reduces long-term mortality and morbidity more than PCI in multivessel coronary disease. 
  • ANTARCTIC: platelet function testing to adjust therapy. 
  • Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing. 
  • Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators. 
  • Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study. 
  • Achieving optimal results with standard balloon angioplasty: can baseline and angiographic variables predict stent-like outcomes? 
  • Acute and long-term cost implications of coronary stenting. 
  • Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. 
  • Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. 
  • Acute hemodynamic changes during carotid artery stenting. 
  • Acute ischaemic stroke interventions: large vessel occlusion and beyond. 
  • Acute myocardial infarction and cardiac arrest due to coronary artery perforation after mitral valve surgery: successful treatment with a covered stent. 
  • Acute myocardial infarction: safety of cardiac MR imaging after percutaneous revascularization with stents. 
  • Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study). The ERASER Investigators. 
  • Acute ureteral obstruction following transvaginal oocyte retrieval for IVF. 
  • Adenosine diphosphate-induced platelet-fibrin clot strength: a new thrombelastographic indicator of long-term poststenting ischemic events. 
  • Adjuvant therapy for intracoronary stents. Investigations in atherosclerotic swine. 
  • Advancing Toward 3D Printing of Bioresorbable Shape Memory Polymer Stents. 
  • Advancing biomarker science in the 21st century. 
  • An endoluminal method of hemorrhage control and repair of ruptured abdominal aortic aneurysms. 
  • An endovascular model of ischemic myopathy from peripheral arterial disease. 
  • Anabolic steroids, acute myocardial infarction and polycythemia: a case report and review of the literature. 
  • Analysis of anatomic factors and age in patients undergoing carotid angioplasty and stenting. 
  • Analysis of infection risk following covered stent exclusion of pseudoaneurysms in prosthetic arteriovenous hemodialysis access grafts. 
  • Analysis of outcomes following failed endovascular treatment of chronic limb ischemia. 
  • Anastomotic contracture and incontinence after radical prostatectomy: a graded approach to management. 
  • Aneurysm of an aberrant right subclavian artery: treatment with PTFE covered stentgraft. 
  • Aneurysmal subarachnoid hemorrhage in patients under 35-years-old: a single-center experience. 
  • Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction. 
  • Angiojet rheolytic thrombectomy in infants following cardiac surgery. 
  • Anterior-to-posterior circulation approach for mechanical thrombectomy of an acutely occluded basilar artery using the penumbra aspiration system. 
  • Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors. 
  • Antiplatelet resistance--fact or myth? 
  • Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update. 
  • Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. 
  • Antithrombotic therapy in patients undergoing coronary angioplasty. 
  • Antithrombotic therapy in patients undergoing coronary angioplasty. 
  • Antithrombotic therapy in patients undergoing percutaneous coronary intervention. 
  • Aortic aneurysmal disease: assessment of stent-graft treatment-CT versus conventional angiography. 
  • Aortic dissection after angioplasty and stenting of an aortic coarctation: detection by intravascular ultrasonography but not transesophageal echocardiography. 
  • Aortic remodeling in type B aortic dissection: effects of endovascular stent-graft repair and medical treatment on true and false lumen volumes. 
  • Aortoesophageal fistula after thoracic aortic stent-graft placement: a rare but catastrophic complication of a novel emerging technique. 
  • Aortoiliac angulation and the need for secondary procedures to secure stent graft fixation: which angle is important? 
  • Appropriateness of percutaneous coronary intervention. 
  • Arteriovenous Graft Delamination and Dissection as a Cause of Graft Dysfunction. 
  • Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off Model. 
  • Assessing the impact of ureteral stent design on patient comfort. 
  • Assessment of contemporary stent deployment using intravascular ultrasound. 
  • Association Between Device Type and Type IIIb Endoleaks Following Thoracic Endovascular Aortic Repair. 
  • Association between ST segment Resolution following Fibrinolytic therapy or Intracoronary stenting, and Reinfarction in the same myocardial region in the DANAMI-2 study population. 
  • Atherosclerotic renal artery stenosis in the post-CORAL era part 1: the renal penumbra concept and next-generation functional diagnostic imaging. 
  • Autopsy validation study of the academic research consortium stent thrombosis definition. 
  • Bacterial biofilm within diseased pancreatic and biliary tracts. 
  • Bailout use of platelet glycoprotein IIb-IIIa inhibition during coronary stent implantation: observations from the ESPRIT trial. 
  • Balloon angioplasty and stenting of multiple intralobar pulmonary arterial stenoses in adult patients. 
  • Balloon-Mounted Stents for Treatment of Refractory Flow Diverting Device Wall Malapposition. 
  • Barriers and opportunities of cortical stimulation via cerebral venous approach. 
  • Baseline characteristics and therapeutic goals in the New Approaches to Coronary Intervention (NACI) registry. 
  • Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. 
  • Benign prostatic hyperplasia. New concepts in the 1990s. 
  • Bilateral vocal cord paralysis following stent placement for proximal esophageal stricture. 
  • Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors. 
  • Biliary self-expandable metal stents do not adversely affect pancreaticoduodenectomy. 
  • Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction. 
  • Biodegradable Shape Memory Polymers in Medicine. 
  • Biodegradable stents: the future of interventional cardiology? 
  • Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT. 
  • Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study. 
  • Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry. 
  • Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention. 
  • Blinded Physiological Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention: The DEFINE PCI Study. 
  • Bridging American-Canadian health care outcome differences: is there really a gap? 
  • Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week. 
  • Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. 
  • CORR Insights(®): Risk of Post-TKA Acute Myocardial Infarction in Patients With a History of Myocardial Infarction or Coronary Stent. 
  • CYP2C19 pharmacogenetics versus standard of care dosing for selecting antiplatelet therapy in patients with coronary artery disease: A meta-analysis of randomized clinical trials. 
  • Carotid Endarterectomy Versus Carotid Stenting to Treat Carotid Stenosis: There Is More to Than Meets the Eye. 
  • Carotid Endarterectomy to Remove Retained Solitaire Stent Retriever inside Carotid Stent after Mechanical Thrombectomy. 
  • Carotid artery angioplasty and stent placement: postprocedural hemorrhage and delayed pseudoaneurysm formation. 
  • Carotid artery stenting versus carotid endarterectomy: a comprehensive meta-analysis of short-term and long-term outcomes. 
  • Carotid endarterectomy versus carotid angioplasty with or without stenting for treatment of carotid artery stenosis: an updated meta-analysis of randomized controlled trials. 
  • Carotid stenting and endarterectomy and contralateral carotid occlusion. 
  • Carotid web: an occult mechanism of embolic stroke. 
  • Cavernous carotid aneurysms: a new treatment paradigm in the era of flow diversion. 
  • Cerebral blood flow changes after endovascular treatment of cerebrovascular stenoses. 
  • Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative). 
  • Characteristics, management, and outcomes of cocaine-positive patients with acute coronary syndrome (from the National Cardiovascular Data Registry). 
  • Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. 
  • Choosing between percutaneous coronary intervention and coronary artery bypass grafting for patients with multivessel disease: what can we learn from the Arterial Revascularization Therapy Study (ARTS)? 
  • Clinical Characteristics, Procedural Factors, and Outcomes of Percutaneous Coronary Intervention in Patients With Mechanical and Bioprosthetic Heart Valves. 
  • Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG? 
  • Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention. 
  • Clinical and angiographic efficacy of a self-expanding nitinol stent in saphenous vein graft atherosclerotic disease: the Stent Comparative Restenosis (SCORES) Saphenous Vein Graft Registry. 
  • Clinical and angiographic outcomes in diabetic patients following single or multivessel stenting in the COSTAR II randomized trial. 
  • Clinical characteristics predict benefits from eptifibatide therapy during coronary stenting: insights from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy (ESPRIT) trial. 
  • Clinical considerations with the use of antiplatelet therapy in patients undergoing percutaneous coronary intervention. 
  • Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry. 
  • Clinical end points in coronary stent trials: a case for standardized definitions. 
  • Clinical implications of systemic inflammatory response syndrome following thoracic aortic stent-graft placement. 
  • Clinical outcome after coronary artery revascularization and lung transplantation. 
  • Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II. 
  • Clinical outcomes in patients with the concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention: an analysis from the Guthrie Health Off-Label Stent (GHOST) investigators. 
  • Clinical utility of serial and continuous ST-segment recovery assessment in patients with acute ST-elevation myocardial infarction: assessing the dynamics of epicardial and myocardial reperfusion. 
  • Clipping Could Be the Best Treatment Modality for Recurring Anterior Communicating Artery Aneurysms Treated Endovascularly. 
  • Clopidogrel dosing in overweight patients: does one size fit all? 
  • Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study. 
  • Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. 
  • Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study. 
  • Clopidogrel resistance: implications for coronary stenting. 
  • Clopidogrel response variability and the advent of personalised antiplatelet therapy. A bench to bedside journey. 
  • Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. 
  • Clopidogrel: the future choice for preventing platelet activation during coronary stenting? 
  • Coaxial Stent Graft inside a Constraining Stent for Transjugular Intrahepatic Portosystemic Shunt Reduction. 
  • Colonic Perforation Secondary to Retained Biliary Stent. 
  • Combined endoscopic ultrasound-guided gastrojejunostomy and anterograde biliary stenting. 
  • Combined use of warfarin and oral P2Y12 inhibitors in patients with atrial fibrillation and acute coronary syndrome. 
  • Commentary: Ductal stenting for ductal-dependent pulmonary blood flow: Time for an exclusive club to expand its membership? 
  • Commentary: Go "all in" the way they do in Texas-Or wait to see how the hand plays out? Extent of distal repair for acute type I dissection. 
  • Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease. 
  • Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial). 
  • Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents. 
  • Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trial. 
  • Comparison of angioplasty with stenting in acute myocardial infarction. 
  • Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. 
  • Comparison of coronary artery dynamics pre- and post-stenting. 
  • Comparison of coronary stenting versus conventional balloon angioplasty on five-year mortality in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. 
  • Comparison of flow diversion and coiling in large unruptured intracranial saccular aneurysms. 
  • Comparison of in-hospital outcomes of patients with versus without previous carotid endarterectomy undergoing carotid stenting (from the German ALKK CAS Registry). 
  • Comparison of long-term (seven year) outcomes among patients undergoing percutaneous coronary revascularization with versus without stenting. 
  • Comparison of nationwide trends in 30-day readmission rates after carotid artery stenting and carotid endarterectomy. 
  • Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial). 
  • Comparison of self-expanding and balloon-expandable stents for the reduction of restenosis. 
  • Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study). 
  • Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. 
  • Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators. 
  • Complementary effects of thienopyridine pretreatment and platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention; results from the ESPRIT trial. 
  • Complete resolution of systemic venous baffle obstruction and baffle leak using the Gore Excluder covered stent in two patients with transposition of the great arteries and prior Mustard procedure. 
  • Complicated postpartum type B aortic dissection and endovascular repair. 
  • Complications Following Therapeutic Bronchoscopy for Malignant Central Airway Obstruction: Results of the AQuIRE Registry. 
  • Complications and solutions in presurgical nasoalveolar molding therapy. 
  • Complications of pancreaticoduodenectomy after neoadjuvant chemoradiation in patients with and without preoperative biliary drainage. 
  • Concomitant endovascular repair of descending thoracic and abdominal aortic aneurysm. 
  • Congenital coarctation and Takayasu's arteritis: aortic stenting employing intravascular ultrasound. 
  • Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. 
  • Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. 
  • Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective. 
  • Consistency of financial interest disclosures in the biomedical literature: the case of coronary stents. 
  • Constructing the informatics and information technology foundations of a medical device evaluation system: a report from the FDA unique device identifier demonstration. 
  • Contemporary percutaneous treatment of infrapopliteal arterial disease: a practical approach. 
  • Core curriculum for endoluminal stent placement. 
  • Coronary artery stents. American College of Cardiology. 
  • Coronary artery stents: evaluating new designs for contemporary percutaneous intervention. 
  • Coronary intervention for persistent occlusion after myocardial infarction. 
  • Coronary interventions "to go": Is faster better? 
  • Coronary stent patency: dual-energy multidetector CT assessment in a pilot study with anthropomorphic phantom. 
  • Correction of central venous stenoses: use of angioplasty and vascular Wallstents. 
  • Correlations between epicardial flow, microvascular reperfusion, infarct size and clinical outcomes in patients with anterior versus non-anterior myocardial infarction treated with primary or rescue angioplasty: analysis from the EMERALD trial. 
  • Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma. 
  • Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial. 
  • Costs of interventional cardiac procedures. 
  • Could stent design affect platelet activation? Results of the Platelet Activation in STenting (PAST) Study. 
  • Covered transjugular intrahepatic portosystemic shunts: accuracy of ultrasound in detecting shunt malfunction. 
  • Creation of an Extraluminal Arterial Bypass Graft Using a Commercially Available Self-Expanding Stent Graft: Feasibility Study in a Porcine Model. 
  • Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document. 
  • Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease. 
  • Current management of aortic arch lesions with hybrid procedures: a tailored approach to a progressive disease. 
  • Current multicentre studies with the excimer laser: design and aims. 
  • Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies. 
  • Current status of biodegradable stents. 
  • Cystic duct leak after laparoscopic cholecystectomy despite preoperative sphincterotomy. 
  • Decision models for assessing the cost effectiveness of drug-eluting stents. 
  • Defining and utilizing surrogates in the evaluation of coronary stents: what do we really want and need to know? 
  • Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk. 
  • Delayed thrombin-induced platelet-fibrin clot generation by clopidogrel: a new dose-related effect demonstrated by thrombelastography in patients undergoing coronary artery stenting. 
  • Delivery catheter entrapment during deployment of expandable metal stents. 
  • Deployment of a previously embolized, unexpanded, and disarticulated Palmaz-Schatz stent. 
  • Design and methodology of the Occluded Artery Trial (OAT). 
  • Detailed analysis of polymer response to delivery balloon expansion of drug-eluting stents versus bare metal stents. 
  • Detection of broken sutures and metal-ring fractures in AneuRx stent-grafts by using three-dimensional CT angiography after endovascular abdominal aortic aneurysm repair: association with late endoleak development and device migration. 
  • Detection of endograft fractures with multidetector row computed tomography. 
  • Determination of platelet aggregation inhibition during percutaneous coronary intervention with the platelet function analyzer PFA-100. 
  • Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes. 
  • Diabetes Mellitus with Chronic Complications in Relation to Carotid Endarterectomy and Carotid Artery Stenting Outcomes. 
  • Diagnosing coronary arterial stent thrombosis and arterial closure. 
  • Difficulties in applying clinical trial information to the practice setting: case of a high-cost drug. 
  • Disposable devices for RIRS: where do we stand in 2013? What do we need in the future? 
  • Distance from the coronary ostium to the culprit lesion in acute ST-elevation myocardial infarction and its implications regarding the potential prevention of proximal plaque rupture. 
  • Diverse Use of the WEB Device: A Technical Note on WEB Stenting and WEB Coiling of Complex Aneurysms. 
  • Dollars and stents: the economics of drug-eluting stents. 
  • Dorsal onlay urethroplasty for urethral stricture repair. 
  • Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. 
  • Downstream testing and subsequent procedures after coronary computed tomographic angiography following coronary stenting in patients ≥65 years of age. 
  • Drug-Eluting Versus Bare-Metal Stents in Older Patients: A Meta-Analysis of Randomized Controlled Trials. 
  • Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease. 
  • Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patients. 
  • Drug-eluting stents "deliver heartburn": how do we spell relief going forward? 
  • Drug-eluting stents in acute myocardial infarction: is science catching up with practice? 
  • Drug-eluting versus bare metal stenting in acute myocardial infarction. A clinical review. 
  • Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia. 
  • Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry. 
  • Duplex ultrasound scanning versus computed tomographic angiography for postoperative evaluation of endovascular abdominal aortic aneurysm repair. 
  • Durability of platelet inhibition by clopidogrel. 
  • Early and late outcome following deployment of a new flexible tantalum intracoronary stent in dogs. 
  • Early carotid artery stenting and angioplasty in patients with acute ischemic stroke. 
  • Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators. 
  • Economic impact of drug-eluting stents on hospital systems: a disease-state model. 
  • Editorial Comment. 
  • Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION. 
  • Effect of Smoking Cessation on the Pharmacokinetics and Pharmacodynamics of Clopidogrel after PCI: The Smoking Cessation Paradox Study. 
  • Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT). 
  • Effect of adjunctive dipyridamole to DAPT on platelet function profiles in stented patients with high platelet reactivity. The result of the ACCEL-DIP Study. 
  • Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS 1b study. 
  • Effect of coronary target lesion revascularization on late cardiac events after insertion of sirolimus-eluting or bare metal stents. 
  • Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy. 
  • Effect of gender on the outcomes of contemporary percutaneous coronary intervention. 
  • Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial. 
  • Effect of loading with clopidogrel at the time of coronary stenting on platelet aggregation and glycoprotein IIb/IIIa expression and platelet-leukocyte aggregate formation. 
  • Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stenting. 
  • Effect of race and ethnicity on outcomes with drug-eluting and bare metal stents: results in 423 965 patients in the linked National Cardiovascular Data Registry and centers for Medicare & Medicaid services payer databases. 
  • Effectiveness and safety of carotid artery stenting for significant carotid stenosis in patients with contralateral occlusion (from the German ALKK-CAS Registry experience). 
  • Effectiveness and safety of reduced-dose enoxaparin in non-ST-segment elevation acute coronary syndrome followed by antiplatelet therapy alone for percutaneous coronary intervention. 
  • Effectiveness of percutaneous coronary intervention in cardiac allograft vasculopathy. 
  • Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction. 
  • Effects of 308 nanometer excimer laser energy on 316 L stainless-steel stents: implications for laser atherectomy of in-stent restenosis. 
  • Efficacy and safety of minimal dose (< or =1,000 units) unfractionated heparin with abciximab in percutaneous coronary intervention. 
  • Efficacy of Intramuscular Ketorolac for Preventing Renal Colic Post Stent Removal: Randomized Controlled Trial. 
  • Efficacy of intravesical ropivacaine injection on urinary symptoms following ureteral stenting: a randomized, controlled study. 
  • Elderly Woman With Pain and Numbness in Left Hand. 
  • Elective percutaneous coronary intervention using broad-spectrum antiplatelet therapy (eptifibatide, clopidogrel, and aspirin) alone, without scheduled unfractionated heparin or other antithrombin therapy. 
  • Embolic protection and platelet inhibition during renal artery stenting. 
  • Emergent ureteric stent vs percutaneous nephrostomy for obstructive urolithiasis with sepsis: patterns of use and outcomes from a 15-year experience. 
  • Endoscopic Management of an Excluded Gastric Segment after Reversal of Roux-en-Y Gastric Bypass. 
  • Endoscopic palliation of a biliocutaneous fistula with expandable metal stents. 
  • Endoscopic removal of metallic airway stents. 
  • Endoscopic versus percutaneous drainage of post-operative peripancreatic fluid collections following pancreatic resection. 
  • Endoscopy after esophagectomy: Safety demonstrated in a porcine model. 
  • Endourological management of a large distal ureteral calculus in a patient with ureterosigmoidostomy diversion. 
  • Endovascular Repair of Blunt Thoracic Aortic Trauma: Is Postimplant Hypertension an Incidental Finding? 
  • Endovascular Treatment of Venous Sinus Stenosis in Idiopathic Intracranial Hypertension: Complications, Neurological Outcomes, and Radiographic Results. 
  • Endovascular Treatment of a Traumatic Thoracic Aortic Injury in an Eight-Year Old Patient: Case Report and Review of Literature. 
  • Endovascular intervention for acute ischemic stroke in light of recent trials. 
  • Endovascular management of inadvertent brachiocephalic arterial catheterization. 
  • Endovascular repair of an acute symptomatic carotid artery dissection through the false dissecting carotid lumen. 
  • Endovascular repair of descending thoracic aneurysms: results with "on-label" application in the post Food and Drug Administration approval era. 
  • Endovascular stent graft repair of an infrarenal abdominal aortic aneurysm with a horseshoe kidney. 
  • Endovascular stent grafting of a left ventricular assist device outflow graft pseudoaneurysm. 
  • Endovascular stent therapy for extracranial and intracranial carotid artery dissection: single-center experience. 
  • Endovascular stenting of the abdominal aorta following renal transplantation. 
  • Endovascular thoracic aortic aneurysm repair with concomitant myocardial and carotid revascularization. 
  • Endovascular treatment of a large aneurysm arising from a basilar trunk fenestration using the waffle-cone technique. 
  • Endovascular treatment of a traumatic visceral aneurysm. 
  • Endovascular treatment of bilateral carotid artery pseudoaneurysms after blunt carotid injury. 
  • Endovascular treatment of inadvertent cannulation of the vertebro-subclavian arterial junction. 
  • Endovascular treatment of patients with intracranial stenosis with moyamoya-type collaterals. 
  • Epidemiology, risk factors, and management of peripheral vascular disease. 
  • Eptifibatide in percutaneous coronary intervention. A review. 
  • Estimating the nationwide, hospital based economic impact of pediatric urolithiasis. 
  • Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention. 
  • Evaluating laryngotracheal stenosis in a canine model with virtual bronchoscopy. 
  • Evaluating the effectiveness of a rapidly adopted cardiovascular technology with administrative data: the case of drug-eluting stents for acute coronary syndromes. 
  • Evaluating the impact of public health notification: Duke clopidogrel experience. 
  • Evaluation and Treatment of Blunt Pelvic Trauma. 
  • Evaluation and management of blunt cerebrovascular injury: A practice management guideline from the Eastern Association for the Surgery of Trauma. 
  • Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). 
  • Evaluation of a dissolvable ureteral drainage stent in a Swine model. 
  • Evaluation of poly(L-lactic acid) as a material for intravascular polymeric stents. 
  • Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent system. 
  • Evolving revascularization approaches for myocardial ischemia. 
  • Evolving trends in interventional device use and outcomes: results from the National Cardiovascular Network Database. 
  • Exosome-eluting stents for vascular healing after ischaemic injury. 
  • Expanding opportunities to understand quality and outcomes of peripheral vascular interventions: The ACC NCDR PVI Registry. 
  • Expeditious method of difficult ureteral stent change with preservation of ureteral access. 
  • Extending the indications of flow diversion to small, unruptured, saccular aneurysms of the anterior circulation. 
  • External Ventricular Drain and Hemorrhage in Aneurysmal Subarachnoid Hemorrhage Patients on Dual Antiplatelet Therapy: A Retrospective Cohort Study. 
  • Extracranial carotid artery stenosis. 
  • Failure of clopidogrel to reduce platelet reactivity and activation following standard dosing in elective stenting: implications for thrombotic events and restenosis. 
  • Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial). 
  • Feasibility of real-time magnetic resonance-guided stent-graft placement in a swine model of descending aortic dissection. 
  • Femoropopliteal In-Stent Restenosis. 
  • Fenestrated and branched endografts for the treatment of thoracoabdominal aortic aneurysms: a systematic review. 
  • First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). 
  • Five-year outcomes of endovascular repair of complicated acute type B aortic dissections. 
  • Fixing the heart: must the brain pay the price? 
  • Flexible ureteroscopy in conjunction with in situ lithotripsy for lower pole calculi. 
  • Flow diversion for small caliber vessel aneurysms: efficacy, safety, and functional outcome. 
  • Focal pulmonary edema: a complication of endovascular stent dilatation of pulmonary artery stenoses. 
  • For how long should treatment with clopidogrel be continued after coronary stent implantation? 
  • Frequency and outcomes of acute renal failure following thoracic aortic stent-graft placement. 
  • Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials). 
  • Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. 
  • Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes. 
  • Fully covered self-expandable metallic stents in the management of complex biliary leaks: preliminary data - a case series. 
  • Gadolinium-enhanced CT angiography of endovascular stent-grafts. 
  • Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. 
  • Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. 
  • Geographic variation in carotid revascularization among Medicare beneficiaries, 2003-2006. 
  • Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry. 
  • Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists. 
  • Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective. 
  • Gone but not forgotten: the case for drug-eluting stents in percutaneous revascularization of the chronic coronary total occlusion. 
  • Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week. 
  • Guided remote endarterectomy for superficial femoral artery occlusions: a technical note. 
  • Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial). 
  • Hemorrhage associated with ventriculoperitoneal shunt placement in aneurysmal subarachnoid hemorrhage patients on a regimen of dual antiplatelet therapy: a retrospective analysis. 
  • Hemorrhage risk with transjugular intrahepatic portosystemic shunt (TIPS) insertion at the main portal vein bifurcation with stent grafts. 
  • Highlights from the American Heart Association annual scientific sessions 2001: November 11 to 14, 2001. 
  • Highlights of the Year in JACC 2006. 
  • Hospital percutaneous coronary intervention volume and outcome: does it matter? 
  • How asymptomatic is asymptomatic carotid stenosis? 
  • Hybrid procedures in the treatment of thoracoabdominal aortic aneurysms: a systematic review. 
  • Hybrid thoracoabdominal aortic aneurysm repair: concomitant visceral revascularization and endovascular aneurysm exclusion. 
  • Identifying patients at risk for premature discontinuation of thienopyridine after coronary stent implantation. 
  • Iliac arterial injuries after endovascular repair of abdominal aortic aneurysms: correlation with iliac curvature and diameter. 
  • Images for surgeons. Concomitant open surgical repair of an abdominal aortic aneurysm and endovascular repair of a thoracic aortic aneurysm. 
  • Imaging of the thoracic aorta before and after stent-graft repair of aneurysms and dissections. 
  • Impact and determinants of left ventricular function in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction. 
  • Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial. 
  • Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. 
  • Impact of aortoiliac tortuosity on endovascular repair of abdominal aortic aneurysms: evaluation of 3D computer-based assessment. 
  • Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial). 
  • Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. 
  • Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. 
  • Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction--the smoker's paradox revisited. 
  • Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial). 
  • Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trial. 
  • Importance of measurement of platelet reactivity to ADP in patients with coronary artery disease: an historical account. 
  • Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. 
  • Important considerations for trials for peripheral arterial disease: Lessons learned from the paclitaxel mortality signal: A report on behalf of the registry assessment for peripheral interventional Devices (RAPID) Paclitaxel Pathways Program. 
  • Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials. 
  • Improved delivery of the Neuroform 3 stent: technical note. 
  • In Reply: The Safety and Efficacy of Continuous Tirofiban as a Monoantiplatelet Therapy in the Management of Ruptured Aneurysms Treated Using Stent-Assisted Coiling or Flow Diversion and Requiring Ventricular Drainage. 
  • In Vitro Evidence for the Role of Cytokine Storm in the Generation of Stent Thrombosis in COVID-19 Patients. 
  • In search for an optimal antithrombotic regimen in patients with atrial fibrillation undergoing stenting. 
  • In situ bypass and extra-anatomic bypass procedures result in similar survival in patients with secondary aortoenteric fistulas. 
  • In vitro evaluation of the effectiveness of distal protection in the prevention of cerebral thromboembolism during carotid stent placement. 
  • In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin. 
  • In-stent pseudo-restenosis due to an organized thrombus six months after implantation of a sirolimus-eluting stent. 
  • Incidence and predictors of major vascular complications after percutaneous coronary intervention in the glycoprotein IIb/IIIa platelet inhibitor era. 
  • Incidence of cerebral ischemic events after discontinuation of clopidogrel in patients with intracranial aneurysms treated with stent-assisted techniques. 
  • Incidence, impact, and predictors of cranial nerve palsy and haematoma following carotid endarterectomy in the international carotid stenting study. 
  • Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry. 
  • Increased mortality after implantation of first generation drug-eluting stents: seeing the smoke, where is the fire? 
  • Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate? 
  • Index and follow-up costs of endovascular abdominal aortic aneurysm repair from the Endurant Stent Graft System Post Approval Study (ENGAGE PAS). 
  • Infectious aortitis and spondylodiscitis in patients with endovascular stents. 
  • Influence of stent design and use of protection devices on outcome of carotid artery stenting: a pooled analysis of individual patient data. 
  • Influence of the Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: results from the National Cardiovascular Network Database. 
  • Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction. 
  • Integrative biomechanics: A paradigm for clinical applications of fundamental mechanics 
  • Interatrial Stent to Treat Stiff Left Atrium Syndrome. 
  • Intervention for Supravalvar Pulmonary Stenosis After the Arterial Switch Operation. 
  • Interventional and new approaches to stroke prevention: introduction. 
  • Intracoronary bolus administration of eptifibatide during percutaneous coronary stenting for non ST elevation myocardial infarction and unstable angina. 
  • Intracoronary brachytherapy: time to sell short? 
  • Intracoronary ultrasound evaluation of interventional technologies. 
  • Intracranial Atherosclerosis: A Disease of Functional, not Anatomic Stenosis? How Trans-Stenotic Pressure Gradients Can Help Guide Treatment. 
  • Intraoperative pulmonary artery stenting: an alternative technique for the management of pulmonary artery stenosis. 
  • Intravascular ultrasound in the management of acute coronary artery dissection: a case report. 
  • Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. 
  • Is Paclitaxel Causing Mortality During Lower-Extremity Revascularization? 
  • Is meta-analysis the optimal method to decide the duration of antiplatelet therapy in diabetic patients treated with drug‑eluting stenting? 
  • Is packing density important in stent-assisted coiling? 
  • Ischemia-driven target vessel revascularization after-primary percutaneous coronary intervention: patients at risk and their outcomes. 
  • Ischemic disease of the kidney: how and why to consider revascularization. 
  • Kissing stents in the aortic bifurcation. 
  • Knowledge gaps in surgical management for aortic dissection. 
  • Laparoscopic dismembered pyeloplasty. 
  • Laparoscopic-assisted ERCP and EUS in patients with prior Roux-en-Y gastric bypass surgery: a dual-center case series experience. 
  • Laser Doppler flowmetry: a clinical test of pulpal vitality. 
  • Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy. 
  • Left-Sided Varicocele as a Rare Presentation of May-Thurner Syndrome. 
  • Lessons learned in patients with large steinstrasse. 
  • Letter by Gurbel et al regarding article, "Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement". 
  • Letter by Moris and Avgerinos Regarding Article, "Long-Term Outcome After Carotid Artery Stenting: A Population-Based Matched Cohort Study". 
  • Local administration of L-703,081 using a composite polymeric stent reduces platelet deposition in canine coronary arteries. 
  • Local delivery of heparin post-PTCA: a multicenter randomized pilot study. 
  • Local drug delivery of argatroban from a polymeric-metallic composite stent reduces platelet deposition in a swine coronary model. 
  • Long-Term Survival After Bovine Pericardial Versus Porcine Stented Bioprosthetic Aortic Valve Replacement: Does Valve Choice Matter? 
  • Long-term antithrombotic therapy after venous stent placement. 
  • Long-term clinical and economic analysis of the Endeavor drug-eluting stent versus the Driver bare-metal stent: 4-year results from the ENDEAVOR II trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions). 
  • Long-term clinical outcomes following coronary stenting. 
  • Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention. 
  • Long-term follow-up of Acucise incision of ureteropelvic junction obstruction and ureteral strictures. 
  • Long-term mortality of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation for acute and stable coronary artery disease. 
  • Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. 
  • Long-term outcomes of older diabetic patients after percutaneous coronary stenting in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008. 
  • MDCT angiography of thoracic aorta endovascular stent-grafts: pearls and pitfalls. 
  • Malignant gastric outlet obstruction: bridging another divide. 
  • Management of Lung Transplant Bronchial Stenosis With Mitomycin C. 
  • Management of esophageal perforation after therapeutic upper gastrointestinal endoscopy. 
  • Management of gastrointestinal bleeding in patients with cirrhosis. 
  • Management of major biliary complications after laparoscopic cholecystectomy. 
  • Management of nephropleural fistula after supracostal percutaneous nephrolithotomy. 
  • Management of occluded metal stents in malignant biliary obstruction: similar outcomes with second metal stents compared to plastic stents. 
  • Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. 
  • Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. 
  • Management of urethral stricture disease: developing options for surgical intervention. 
  • Massive steinstrasse after treatment of a staghorn calculus. 
  • Matched Comparison of Flow Diversion and Coiling in Small, Noncomplex Intracranial Aneurysms. 
  • Mechanical Thrombectomy of Acutely Occluded Flow Diverters. 
  • Mechanical Thrombectomy of Acutely Occluded Flow-Diverters - Neuroendovascular Surgical Technique Demonstration: 2-Dimensional Operative Video. 
  • Medical economics and the assessment of value in cardiovascular medicine: Part II. 
  • Medication, reperfusion therapy and survival in a community-based setting of hospitalised myocardial infarction. 
  • Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007. 
  • Meta-analysis of drug eluting stents compared with bare metal stents in high bleeding risk patients undergoing percutaneous coronary interventions. 
  • Methodological remarks concerning the recent meta-analysis of carotid artery stenting vs carotid endarterectomy. 
  • Midterm outcomes after treatment of type II endoleaks associated with aneurysm sac expansion. 
  • Midterm outcomes in patients undergoing endovascular repair of thoracic aortic aneurysms and penetrating atherosclerotic ulcers using the RelayPlus stent graft. 
  • Minimally invasive glaucoma surgery in childhood glaucoma. 
  • More Versus Better: Learning From the Medtronic Valiant Navion Recall. 
  • Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study. 
  • Motion--pancreatic endoscopy is useful for the pain of chronic pancreatitis: arguments for the motion. 
  • Multicenter randomized trial of the spiral Z-stent compared with the Wallstent for malignant biliary obstruction. 
  • Mycobacterium chelonae canaliculitis associated with SmartPlug use. 
  • Myonecrosis following stent placement: association between impaired TIMI myocardial perfusion grade and MRI visualization of microinfarction. 
  • Nitinol intravascular stent: results of preclinical evaluation. 
  • Nitinol stone retrieval-assisted ureteroscopic management of lower pole renal calculi. 
  • Novel Treatment of Cerebral Vasospasm Using Solitaire Stent Retriever-Assisted Angioplasty: Case Series. 
  • Novel approach to the treatment of distal malperfusion secondary to ascending aortic dissection. 
  • Novel approaches to clinical trials: device-related infections. 
  • Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial. 
  • Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial. 
  • Objective performance goals of safety and blood pressure efficacy for clinical trials of renal artery bare metal stents in hypertensive patients with atherosclerotic renal artery stenosis. 
  • Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development. 
  • Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel. 
  • One-year results of the GORE EXCLUDER Conformable AAA Endoprosthesis system in the United States regulatory trial. 
  • Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial. 
  • Outcome analysis of urethral wall stent insertion with artificial urinary sphincter placement for severe recurrent bladder neck contracture following radical prostatectomy. 
  • Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. 
  • Outcome of endoscopic minor papillotomy in patients with symptomatic pancreas divisum. 
  • Outcomes after late explantation of aortic endografts depend on indication for explantation. 
  • Outcomes after percutaneous coronary artery revascularization procedures for cardiac allograft vasculopathy in pediatric heart transplant recipients: A multi-institutional study. 
  • Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. 
  • Outcomes following interventions in small coronary arteries with the use of hand-crimped Palmaz-Schatz stents. 
  • Outcomes of Thoracic Endovascular Aortic Repair in Acute Type B Aortic Dissection: Results From the Valiant United States Investigational Device Exemption Study. 
  • Outcomes of atrioesophageal fistula following catheter ablation of atrial fibrillation treated with surgical repair versus esophageal stenting. 
  • Outcomes of bail-out stenting for suboptimal balloon angioplasty during primary intervention in acute myocardial infarction (The CADILLAC trial). 
  • Outcomes of metallic stents for malignant ureteral obstruction. 
  • Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trial. 
  • Outcomes of prosthetic hemodialysis grafts after deployment of bare metal versus covered stents at the venous anastomosis. 
  • Outcomes of tracheobronchial stents in patients with malignant airway disease. 
  • Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. 
  • Ovarian hyperstimulation causing ureteral obstruction in a pregnant woman. 
  • Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. 
  • PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 Study. 
  • Palliating Premature Infants With Obstructed Total Anomalous Pulmonary Venous Connection via Catheterization. 
  • Pan-aortic hybrid treatment of mega-aorta syndrome. 
  • Part I: Identifying holes in the safety net. 
  • Patterns and predictors of stress testing modality after percutaneous coronary stenting: data from the NCDR(®). 
  • Percutaneous Thrombectomy in Patients with Occlusions of the Aortoiliac Segment: A Case Series. 
  • Percutaneous and open renal revascularizations have equivalent long-term functional outcomes. 
  • Percutaneous angioplasty and stenting of the superficial femoral artery. 
  • Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura. 
  • Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry. 
  • Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). 
  • Percutaneous coronary intervention versus coronary artery bypass grafting for diabetics with multivessel coronary artery disease: the Korean Multicenter Revascularization Registry (KORR). 
  • Percutaneous endopyelotomy in infants and young children after failed open pyeloplasty. 
  • Percutaneous hepatic vein reconstruction for Budd-Chiari syndrome. 
  • Percutaneous interventions in high-risk patients following Mustard repair of transposition of the great arteries. 
  • Percutaneous revascularization of an extensively diseased saphenous vein bypass graft with a saphenous vein-covered Palmaz stent. 
  • Percutaneous stenting of right pulmonary artery stenosis in fibrosing mediastinitis. 
  • Percutaneous stenting of superior vena cava syndrome: a case report and review of the literature. 
  • Percutaneous vascular stent implantation as treatment for central vascular obstruction due to fibrosing mediastinitis. 
  • Peri-procedural stroke or death in stenting of symptomatic severe intracranial stenosis. 
  • Perioperative management of a neurosurgical patient requiring antiplatelet therapy. 
  • Peripartum management of dual antiplatelet therapy and neuraxial labor analgesia after bare metal stent insertion for acute myocardial infarction. 
  • Peripheral Artery Disease Therapies May Perform Differently in Practice Than in Randomized Trials: The Need for Learning Health Systems. 
  • Peripheral arterial disease: an overview of endovascular therapies and contemporary treatment strategies. 
  • Peripheral vascular complications during transcatheter aortic valve replacement: management and potential role of chronic steroid use. 
  • Periprocedural complication rates are equivalent between symptomatic and asymptomatic patients undergoing carotid angioplasty and stenting. 
  • Pharmacodynamic effects of a new fixed-dose clopidogrel-aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial. 
  • Pharmacodynamic effects of cilostazol versus clopidogrel in stented patients under proton pump inhibitor co-administration: the ACCEL-PARAZOL study. 
  • Pharmacogenetics of Clopidogrel: An Unresolved Issue. 
  • Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients. 
  • Pharmacoinvasive management of acute coronary syndrome in the setting of percutaneous coronary intervention: evidence-based, site- and spectrum-of-care strategies for optimizing patient outcomes in NSTE-ACS. 
  • Piezosurgery in External Dacryocystorhinostomy. 
  • Pipeline Embolization Device for the Treatment of Intracranial Pseudoaneurysms. 
  • Pipeline Embolization Device in the Treatment of Recurrent Previously Stented Cerebral Aneurysms. 
  • Platelet activation after stenting with heparin-coated versus noncoated stents. 
  • Platelet function and total length of intracoronary stents: is there a correlation? 
  • Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial. 
  • Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study. 
  • Point-of-care seeding of nitinol stents with blood-derived endothelial cells. 
  • Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic Acid copolymer. 
  • Power calculations for large multi-arm placebo-controlled studies of dichotomous outcomes. 
  • Power considerations for trials of two experimental arms versus a standard active control or placebo. 
  • Practice patterns and clinical outcomes after hybrid coronary revascularization in the United States: an analysis from the society of thoracic surgeons adult cardiac database. 
  • Practice patterns of ureteral stenting after routine ureteroscopic stone surgery: a survey of practicing urologists. 
  • Prediction of aortoiliac stent-graft length: comparison of measurement methods. 
  • Prediction of one-year mortality among 30-day survivors after primary percutaneous coronary interventions. 
  • Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline. 
  • Predictors of Complications, Functional Outcome, and Morbidity in a Large Cohort Treated With Flow Diversion. 
  • Predictors of Stroke, Myocardial Infarction or Death within 30 Days of Carotid Artery Stenting: Results from the International Carotid Stenting Study. 
  • Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial). 
  • Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. The Percutaneous Excimer Laser Coronary Angioplasty Registry. 
  • Preliminary observations using optical coherence tomography to assess neointimal coverage of a metal stent in a porcine model. 
  • Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents. 
  • Preprocedural three-dimensional planning aids in transcatheter ductal stent placement: A single-center experience. 
  • Presurgical nasoalveolar molding in infants with cleft lip and palate. 
  • Prevention of restenosis: medical treatment and procedures for iliac occlusive disease. 
  • Primary renal artery stenting: characteristics and outcomes after 363 procedures. 
  • Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes-insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. 
  • Prognostic Implications of Post-Intervention Resting Pd/Pa and Fractional Flow Reserve in Patients With Stent Implantation. 
  • Prognostic significance of elevated troponin I after percutaneous coronary intervention. 
  • Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. 
  • Prospective Multicentered Safety and Feasibility Pilot for Endobronchial Intratumoral Chemotherapy. 
  • Prospective multicenter trial of esophageal Z-stent placement for malignant dysphagia and tracheoesophageal fistula. 
  • Provisional stenting strategies: systematic overview and implications for clinical decision-making. 
  • Provisional stenting versus routine stenting: is it worth the price? 
  • Provisional vs. complex stenting strategy for coronary bifurcation lesions: meta-analysis of randomized trials. 
  • Proximal embolic protection versus distal filter protection versus combined protection in carotid artery stenting: A systematic review and meta-analysis. 
  • Proximal migration of a 3 French pancreatic stent in a patient with pancreas divisum: suggested technique for successful retrieval. 
  • Proximal migration of biliary stents: attempted endoscopic retrieval in forty-one patients. 
  • Pseudo-migration of a biliary stent. 
  • Pulmonary stenting for the treatment of sarcoid induced pulmonary vascular stenosis. 
  • Quality of life after late invasive therapy for occluded arteries. 
  • Quality of life impact and recovery after ureteroscopy and stent insertion: insights from daily surveys in STENTS. 
  • Race and sex differences in thrombogenicity: risk of ischemic events following coronary stenting. 
  • Randomized trial in malignant biliary obstruction: plastic vs partially covered metal stents. 
  • Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial. 
  • Rate of change in abdominal aortic aneurysm diameter after endovascular repair. 
  • Real-time detection and alerting for acute ST-segment elevation myocardial ischemia using an implantable, high-fidelity, intracardiac electrogram monitoring system with long-range telemetry in an ambulatory porcine model. 
  • Reconstruction of the rabbit trachea with vascularized auricular perichondrium. 
  • Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts. 
  • Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. 
  • Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention. 
  • Reduction in vascular access site bleeding in sequential abciximab coronary intervention trials. 
  • Regarding "Anesthetic type and risk of myocardial infarction after carotid endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST)". 
  • Regarding "stroke and death after carotid endarterectomy and carotid artery stenting with and without high risk criteria". 
  • Registry Assessment of Peripheral Interventional Devices (RAPID): Registry assessment of peripheral interventional devices core data elements. 
  • Relation of Baseline Hemoglobin Levels and Adverse Events in Patients With Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction Trials). 
  • Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention. 
  • Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trial. 
  • Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy. 
  • Relief of superior vena cava syndrome due to fibrosing mediastinitis using the Palmaz stent. 
  • Remedial operations for failed endovascular therapy of 32 renal artery stenoses in 24 children. 
  • Removal of a UroLume prostatic stent using the holmium laser. 
  • Removal of thrombus by catheter aspiration prior to stenting. 
  • Renal malperfusion: spontaneous renal artery dissection and with aortic dissection. 
  • Repair of a complete glottic-subglottic stenosis with a fibular osseocutaneous free flap. 
  • Reperfusion for acute myocardial infarction: is the future in plastics? 
  • Resistance to antiplatelet drugs: what progress has been made? 
  • Restenosis after coronary angioplasty: an overview. 
  • Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial. 
  • Restenosis rates following vertebral artery origin stenting: does stent type make a difference? 
  • Results with a selective revascularization strategy for left subclavian artery coverage during thoracic endovascular aortic repair. 
  • Retrieval of a migrated Polyflex stent--a novel technique. 
  • Retrograde ascending aortic dissection as an early complication of thoracic endovascular aortic repair. 
  • Retrograde ascending aortic dissection during or after thoracic aortic stent graft placement: insight from the European registry on endovascular aortic repair complications. 
  • Retrograde balloon cautery incision of ureteropelvic junction obstruction. 
  • Retrograde ureteral stents for extrinsic ureteral obstruction: nine years' experience at University of Michigan. 
  • Revascularization Strategies and Outcomes in Elderly Patients With Multivessel Coronary Disease. 
  • Revascularization in stable coronary artery disease. 
  • Reversible bilateral optic tract edema following pipeline-assisted coiling of a large ophthalmic aneurysm: A case report. 
  • Risk Factors For Stroke, Myocardial Infarction, or Death Following Carotid Endarterectomy: Results From the International Carotid Stenting Study. 
  • Risk Factors for Increased Stent-associated Symptoms Following Ureteroscopy for Urinary Stones: Results From STENTS. 
  • Risk factors for failed transverse sinus stenting in pseudotumor cerebri patients. 
  • Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention. 
  • Risk of ventriculostomy-related hemorrhage in patients with acutely ruptured aneurysms treated using stent-assisted coiling. 
  • Role of the distal balloon protection technique in the prevention of cerebral embolic events during carotid stent placement. 
  • Roundtable panel discussion: the role of glycoprotein IIb-IIIa receptor inhibitors in acute ischemic coronary syndromes. 
  • Routine bivalirudin use in percutaneous carotid interventions. 
  • Routine placement of ureteral stents is unnecessary after ureteroscopy for urinary calculi. 
  • Routine postoperative imaging is important after ureteroscopic stone manipulation. 
  • Routine ureteral stenting is not necessary after ureteroscopy and ureteropyeloscopy: a randomized trial. 
  • Safety and Feasibility of Simultaneous Transcarotid Revascularization With Flow Reversal and Coronary Artery Bypass Grafting for Concomitant Carotid Artery Stenosis and Coronary Artery Disease. 
  • Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis and critical examination of current methodologies. 
  • Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database. 
  • Safety and efficacy of the Pipeline Embolization Device in 100 small intracranial aneurysms. 
  • Safety and efficacy of the use of large bore intermediate suction catheters alone or in combination for the treatment of acute cerebral venous sinus thrombosis: A multicenter experience. 
  • Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study. 
  • Safety and efficacy of tirofiban in stent-assisted coil embolization of intracranial aneurysms. 
  • Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). 
  • Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms. 
  • Salvage Neuroform stent-assisted coiling for recurrent giant aneurysm after waffle-cone treatment. 
  • Salvaging vascular access and treatment of severe limb edema: case reports on the novel use of the hemodialysis reliable outflow vascular access device. 
  • Saphenous vein graft disease: a left main equivalent. 
  • Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. 
  • Screening for asymptomatic carotid artery stenosis: caveat emptor. 
  • Session highlights from the American Heart Association Scientific Sessions: November 9-12, 1997. 
  • Severe and resistant hypertension in an older woman with claudication. 
  • Sex Differential in 15-Hydroxyprostaglandin Dehydrogenase Levels in the Lumen of Human Intracranial Aneurysms. 
  • Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents. 
  • Sharp Recanalization of Chronic Central Venous Occlusions of the Thorax Using a Steerable Coaxial Needle Technique from a Supraclavicular Approach. 
  • Short- and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid services cohort. 
  • Short-term outcomes of balloon angioplasty versus stent placement for patients undergoing primary percutaneous coronary intervention: Implications for patients requiring early coronary artery bypass surgery. 
  • Significance of and risk factors for the development of central airway stenosis after lung transplantation. 
  • Significant variation in P2Y12 inhibitor use after peripheral vascular intervention in Medicare beneficiaries. 
  • Simple vaginal mold for use in the postoperative care of patients with a transverse vaginal septum. 
  • Simplified ureteral stent placement with the assistance of a ureteral access sheath. 
  • Simplified urinary drainage following orthotopic or continent bladder replacement. 
  • Simultaneous restenosis of Taxus and Cypher drug-eluting stents. 
  • Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. 
  • Small-molecule glycoprotein IIb/IIIa inhibitors as adjunctive therapy in percutaneous coronary interventions. 
  • Spontaneous delayed migration/shortening of the pipeline embolization device: report of 5 cases. 
  • Squeezing the "value" from cost data. 
  • Stacked proximal aortic cuffs: an "off-the-shelf" solution for treating focal thoracic aortic pathology. 
  • Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document. 
  • Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document. 
  • State of the Art: Interventional Pulmonology. 
  • Statins do not affect platelet inhibition with clopidogrel during coronary stenting. 
  • Steering between Scylla and Charybdis: Picking out the optimum time of double-J stent removal following renal transplantation. 
  • Stent Graft-induced Aortic Wall Injury: Incidence, Risk Factors, and Outcomes. 
  • Stent Placement Across the Renal Vein Inflow in Patients Undergoing Venous Reconstruction Preserves Renal Function and Renal Vein Patency: Experience in 93 Patients. 
  • Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial. 
  • Stent graft-induced new entry tear (SINE): Intentional and NOT. 
  • Stent impact on the geometry of the carotid bifurcation and the course of the internal carotid artery. 
  • Stent parameters predict major adverse clinical events and the response to platelet glycoprotein IIb/IIIa blockade: findings of the ESPRIT trial. 
  • Stent placement for the diagnosis of upper tract obstruction. 
  • Stent thrombosis: role of compliance and nonresponsiveness to antiplatelet therapy. 
  • Stent-assisted basilar reconstruction for a traumatic vertebral dissection with a large basilar artery thrombosis. 
  • Stent-assisted coil embolization of complex wide-necked bifurcation cerebral aneurysms using the "waffle cone" technique. A review of ten consecutive cases. 
  • Stent-assisted coiling of wide-necked aneurysms in the setting of acute subarachnoid hemorrhage: experience in 65 patients. 
  • Stent/coil treatment of very large and giant unruptured ophthalmic and cavernous aneurysms. 
  • Stenting as monotherapy for uncoilable intracranial aneurysms. 
  • Stenting for Acute Carotid Artery Dissection. 
  • Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis. 
  • Stenting of Subclavian Artery True and False Aneurysms: A Systematic Review. 
  • Stroke after Thoracic Endovascular Aortic Aneurysm Repair: A Silent Enemy that Needs More Caution. 
  • Stuck Between a Clot and a Cold Place: The Specter of Early In-Stent Thrombosis With Therapeutic Hypothermia. 
  • Study to Enhance Understanding of Stent-Associated Symptoms: Rationale and Study Design. 
  • Success of ureteral stents for intrinsic ureteral obstruction. 
  • Successful management of lower-pole moiety ureteropelvic junction obstruction in a partially duplicated collecting system using minimally invasive retrograde endoscopic techniques. 
  • Successful percutaneous coronary intervention with stent implantation in anomalous right coronary arteries arising from the left sinus of valsalva: a report of two cases. 
  • Sudden cardiac death due to large coronary aneurysm successfully treated with a covered stent and ChromaFlo guidance. 
  • Suitability study of current endovascular aortic repair devices based on real-life anatomic data. 
  • Surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experience. 
  • Surrogates, substudies, and real clinical end points in trials of drug-eluting stents. 
  • Surveillance for endoleaks: how to detect all of them. 
  • Symptomatic obstruction of the brachiocephalic and left subclavian arteries obscured by aortic stenosis. 
  • Systematic review of endovascular versus laparoscopic extravascular stenting for treatment of nutcracker syndrome. 
  • Systemic hypersensitivity reaction to endovascular stainless steel stent. 
  • Technical innovation. Using a covered stent (wallgraft) to treat pseudoaneurysms of dialysis grafts and fistulas. 
  • Technical note: A fast and accurate analytical dose calculation algorithm for 125 I seed-loaded stent applications. 
  • Technology Assessment Status Evaluation: stents for gastrointestinal strictures. May, 1997. ASGE. American Society for Gastrointestinal Endoscopy. 
  • Temporal trends in percutaneous coronary intervention outcomes among older patients in the United States. 
  • Temporal trends in target vessel revascularization in clinical practice: long-term outcomes following coronary stenting from the Duke Database for Cardiovascular Disease. 
  • Temporary endovascular bypass: a novel treatment for acute stroke. 
  • The Chicken or the Egg: Hypertension Secondary to Intraoperative Subarachnoid Hemorrhage. 
  • The Cobalt chromium STent with Antiproliferative for Restenosis II (COSTAR II) trial study design: advancing the active-control evaluation of second-generation drug-eluting stents. 
  • The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. 
  • The Montgomery T-tube tracheal stent. 
  • The Role of Endoscopic Management in Afferent Loop Syndrome. 
  • The SILK flow diverter in the treatment of intracranial aneurysms. 
  • The Safety and Efficacy of Continuous Tirofiban as a Monoantiplatelet Therapy in the Management of Ruptured Aneurysms Treated Using Stent-Assisted Coiling or Flow Diversion and Requiring Ventricular Drainage. 
  • The Tube Versus Trabeculectomy Study: interpretation of results and application to clinical practice. 
  • The UroLume stent revisited: the Duke experience. 
  • The Weekend Effect in Carotid Endarterectomy for Symptomatic Carotid Stenosis. 
  • The association of cigarette smoking with enhanced platelet inhibition by clopidogrel. 
  • The balloon anchor technique: a novel technique for distal access through a giant aneurysm. 
  • The benefit of abciximab in percutaneous coronary revascularization is not device-specific. 
  • The bent stent. 
  • The bifurcation stent. 
  • The cart and the horse: the advancing technology of carotid artery stenting. 
  • The complementary use of glycoprotein IIb/IIIa inhibitors and drug-eluting stents in contemporary percutaneous coronary intervention. 
  • The contrast media iohexol causes vasoconstriction of the proximal left anterior descending coronary artery: implications for appropriate stent sizing. 
  • The coronary artery response to implantation of a balloon-expandable flexible stent in the aspirin- and non-aspirin-treated swine model. 
  • The difference between clopidogrel responsiveness and posttreatment platelet reactivity. 
  • The early antiplatelet effects of clopidogrel loading for coronary stenting and the long-term stability of inhibition. 
  • The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to CYP2C19*2 genotype: first experience in patients. 
  • The efficacy of endovascular stenting in the treatment of supraclinoid internal carotid artery blister aneurysms using a stent-in-stent technique. 
  • The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. 
  • The enigma of drug-eluting stents: hope, hype, humility, and advancing patient care. 
  • The evolution of care improves outcome in blunt thoracic aortic injury: A Western Trauma Association multicenter study. 
  • The health care burden of unstable angina. 
  • The importance of intraoperative transesophageal echocardiography in endovascular repair of thoracic aortic aneurysms. 
  • The kinetics of integrilin limited by obesity: a multicenter randomized pharmacokinetic and pharmacodynamic clinical trial. 
  • The link between heightened thrombogenicity and inflammation: pre-procedure characterization of the patient at high risk for recurrent events after stenting. 
  • The relation between CYP2C19 genotype and phenotype in stented patients on maintenance dual antiplatelet therapy. 
  • The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting. 
  • The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor. 
  • The role of glycoprotein IIb/IIIa platelet inhibition in percutaneous coronary intervention in the stent era. 
  • The timing and frequency of complications after peripheral percutaneous transluminal angioplasty and iliac stenting: is a change from inpatient to outpatient therapy feasible? 
  • Therapeutic bronchoscopy improves spirometry, quality of life, and survival in central airway obstruction. 
  • Thin-section multidetector CT angiography of renal artery stents. 
  • Third universal definition of myocardial infarction. 
  • Thoracic aorta endografts: variations in practice among medical specialists. 
  • Thoracic endovascular aortic repair for chronic DeBakey IIIb aortic dissection. 
  • Three-dimensional spiral CT angiography of the abdomen. 
  • Thrombin-Induced Platelet-Fibrin Clot Strength Identified by Thrombelastography: A Novel Prothrombotic Marker of Coronary Artery Stent Restenosis. 
  • Thromboelastography detects inadequate response to abciximab therapy during stent-assisted cerebral aneurysm coil embolization complicated by stroke. 
  • Thromboembolic Events with Enterprise Versus Pipeline: Porcine In Vivo Experiment. 
  • Thromboembolic complications after Neuroform stent-assisted treatment of cerebral aneurysms: the Duke Cerebrovascular Center experience in 235 patients with 274 stents. 
  • Thrombosis and drug-eluting stents: an objective appraisal. 
  • Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. 
  • Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial. 
  • Time dependence of clopidogrel loading effect: platelet activation versus platelet aggregation. 
  • Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry. 
  • Tiny solutions for giant cardiac problems. 
  • To stent or not to stent--that is the question. 
  • Total pulmonary artery occlusion immediately after lung transplantation: successful revascularization with intravascular stents. 
  • Trabecular Microbypass Stent and Phacoemulsification in African American Patients With Open-angle Glaucoma: Outcomes and Effect of Prior Laser Trabeculoplasty. 
  • Transapical Thoracic Endovascular Aortic Repair as a Bridge to Open Repair of an Infected Ascending Aortic Pseudoaneurysm. 
  • Transcatheter Aortic Valve Replacement Complicated by Migrated Coronary Stent. 
  • Transcirculation balloon-assisted stent-supported coil embolization of a basilar tip aneurysm. 
  • Transient Reperfusion-Like Injury following Endovascular Treatment of Chronic Mesenteric Ischemia. 
  • Transition to Ductal Stenting for Single Ventricle Patients Led to Improved Survival: An Institutional Case Series. 
  • Transradial access for carotid artery stenting: a single-center experience. 
  • Transradial approach for the treatment of brain aneurysms using flow diversion: feasibility, safety, and outcomes. 
  • Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial). 
  • Treatment of Acutely Ruptured Cerebral Aneurysms With the Woven EndoBridge Device: Experience Post-FDA Approval. 
  • Treatment of Arm Swelling in Hemodialysis Patients with Ipsilateral Arteriovenous Access and Central Vein Stenosis: Conversion to the Hemodialysis Reliable Outflow Graft versus Stent Deployment. 
  • Treatment of TIPS/biliary fistula-related endotipsitis with a covered stent. 
  • Treatment of an iatrogenic petrous carotid artery pseudoaneurysm with a Symbiot covered stent: technical case report. 
  • Treatment of blister-like aneurysms with the pipeline embolization device. 
  • Treatment of central venous in-stent restenosis with repeat stent deployment in hemodialysis patients. 
  • Treatment strategies in non-ST-elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention: an evidence-based review of clinical trial results and treatment guidelines: report on a roundtable discussion. 
  • Trends in Bare-Metal Stent Use in the United States in Patients Aged ≥65 Years (from the CathPCI Registry). 
  • Trends in settings for peripheral vascular intervention and the effect of changes in the outpatient prospective payment system. 
  • Trials and tribulations of carotid artery stenting: The Interventionalists' perspective on SAPPHIRE, EVA-3S, and SPACE Trials. 
  • Two dimensional arrays for real time 3D intravascular ultrasound. 
  • Type-II endoleaks following endovascular AAA repair: preoperative predictors and long-term effects. 
  • Unconstrained recovery characterization of shape-memory polymer networks for cardiovascular applications. 
  • Understanding operator stent choice in the catheterization laboratory using a pre-procedure survey: Opportunities for quality improvement. 
  • Uniform platelet activation exists before coronary stent implantation despite aspirin therapy. 
  • Unique device identifiers for coronary stent postmarket surveillance and research: a report from the Food and Drug Administration Medical Device Epidemiology Network Unique Device Identifier demonstration. 
  • Unrecognized left main coronary artery disease in patients undergoing interventional procedures. 
  • Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. 
  • Updated evidence on intracoronary abciximab in ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials. 
  • Ureteral Stent-Associated Pain: A Review 
  • Ureteral access sheath facilitates inspection of incision of ureteropelvic junction. 
  • Ureteral reimplantation for inadvertent ureteral injury during radical perineal prostatectomy. 
  • Ureteral stenting and urinary stone management: a systematic review. 
  • Ureteral stenting in laparoscopic colorectal surgery. 
  • Ureteral stents and their use in endourology. 
  • Ureteral stents for impassable ureteroscopy. 
  • Ureteroscopic management of lower-pole renal calculi: technique of calculus displacement. 
  • Ureteroscopic treatment of lower pole calculi: comparison of lithotripsy in situ and after displacement. 
  • Use of a temporary ureteral drainage stent after uncomplicated ureteroscopy: results from a phase II clinical trial. 
  • Use of a vascular reconstruction device to salvage acute ischemic occlusions refractory to traditional endovascular recanalization methods. 
  • Use of computer simulation for determining endovascular skill levels in a carotid stenting model. 
  • Use of stress testing and diagnostic catheterization after coronary stenting: association of site-level patterns with patient characteristics and outcomes in 247,052 Medicare beneficiaries. 
  • Use of the perfusion balloon as a primary dilation device. 
  • Use of ureteral access sheaths in ureteroscopy. 
  • Utility of CT angiography in the identification and characterization of supraclinoid internal carotid artery blister aneurysms. 
  • Utility of remote wireless pressure sensing for endovascular leak detection after endovascular thoracic aneurysm repair. 
  • Utilizing Hybrid Techniques to Maximize Clinical Outcomes in Congenital Heart Disease. 
  • Vale, warfarin: a stentorian farewell. 
  • Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial. 
  • Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial. 
  • Vascularized auricular perichondrium in airway reconstruction: the effects of stenting with and without a mucosal graft. 
  • Venoplasty and Stenting. 
  • Venous sinus stenting is a valuable treatment for fulminant idiopathic intracranial hypertension. 
  • Visual complications after stent-assisted endovascular embolization of paraophthalmic and suprasellar variant superior hypophyseal aneurysms: the Duke Cerebrovascular Center experience in 57 patients. 
  • Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. 
  • Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy. 
  • What is the best measure of thrombotic risks--pretreatment platelet aggregation, clopidogrel responsiveness, or posttreatment platelet aggregation? 
  • Where's the flap? 
  • Who should have a routine early invasive approach after fibrinolytic therapy? 
  • Why coat a stent with polymer? 
  • Wire-reinforced ureteral stents to rescue from nephrostomy tube in extrinsic ureteral obstruction. 
  • Would tirofiban have been shown non-inferior to abciximab had the TENACITY trial not been terminated for financial reasons? 
  • [Carotid stenting with the new slotted tube stent--prospective multicenter study. Essen experiences]]. 
  • [Predictive value of the GRACE discharge score on the long-term out-of-hospital coronary thrombotic events after implantation of drug-eluting stents]. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Brennan, J. Matthew, Associate Professor of Medicine, Medicine, Cardiology
  • Gall, Ken, Professor in the Department of Mechanical Engineering and Materials Science, Thomas Lord Department of Mechanical Engineering and Materials Science
  • Jones, William Schuyler, Associate Professor of Medicine, Medicine, Cardiology
  • Jowell, Paul Simon, Professor of Medicine, Medicine, Gastroenterology
  • Kim, Charles Yoon, Professor of Radiology, Radiology, Interventional Radiology
  • Middleton, John Paul, Professor of Medicine, Medicine, Nephrology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Patel, Uptal Dinesh, Adjunct Professor in the Department of Medicine, Medicine, Nephrology
  • Preminger, Glenn Michael, James F. Glenn, M.D. Distinguished Professor of Urology, Surgery, Urology
  • Reed, Shelby Derene, Professor in Population Health Sciences, Duke Science & Society
  • Stinnett, Sandra Sue, Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Tcheng, James Enlou, Professor of Medicine, School of Medicine